Point72 Hong Kong’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Point72 Hong Kong’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-50,300	Closed	-$18K	–	1159
2016 Q3	$18K	Buy	+50,300	New	+$18K	0.01%	602

Point72 Hong Kong's RXII Position: Q4 2016 in Review

Point72 Hong Kong sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 50,300 shares — an estimated $18K sold.

Point72 Hong Kong first reported a position in RXII in Q3 2016 and held it in 1 quarter. The position peaked at $18K in Q3 2016. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

Point72 Hong Kong reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
Point72 Hong Kong sold 50,300 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $18K.
Point72 Hong Kong first reported a position in GALENA BIOPHARMA INC COM in Q3 2016 and held it in 1 quarter.
Point72 Hong Kong's GALENA BIOPHARMA INC COM position peaked at $18K in Q3 2016.
0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Point72 Hong Kong's 13F filing for Q4 2016, filed 14 Feb 2017.